ClinicalTrials.gg
CompletedNCT05405647Updated Jun 7, 2022

Extra Corporeal Shock Wave Versus Kinesio Tape in Carpal Tunnel Syndrome

An interventional study of Shock wave Therapy and kinesio tape in Carpal Tunnel Syndrome, sponsored by Cairo University. Completed at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2022-06-07.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 11 months after the study started (first participant enrolled Jul 2021, registered Jun 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
01

Study summary

This study would be conducted to answer the following question: was there any difference between the effects of Shock wave versus Kinesio Tape in the treatment of carpal tunnel syndrome for post-menopausal women.

Read the detailed description

Fifty menopausal women with mild to moderate CTS were selected randomly from outpatient clinic of the physical therapy department of El khazendara general hospital, Age was ranged from 45 - 55 years old.

Group A, consisted of 25 patients who received a program of 6 session of Shock wave Therapy on the affected wrist,5 minute per session. Group B Represented the control group, it consisted of 25 patients who received a program of kinesio tape application on the affected wrist for 3 days.

02

Conditions studied

  • Carpal Tunnel Syndrome

Keywords

  • shock wave
  • kinesio tape
  • carpal tunnel syndrome
03

In context

Carpal Tunnel Syndrome

605 studies on the registry are indexed under Carpal Tunnel Syndrome; 138 are open to participants now.

This study's enrollment of 50 is below the median of 60 across 457 interventional studies indexed under Carpal Tunnel Syndrome.

Browse Carpal Tunnel Syndrome studies →

Lead sponsor

Cairo University is the lead sponsor of 4,909 studies on the registry; 1,445 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • -Age was ranged from 45 - 55 years old
  • All subjects would not take analgesics by another route during the study.

Exclusion criteria

Exclusion Criteria:

  • Patients had previous carpal tunnel release.
  • Skin over sensitivity of some patients to the tape.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (actual)

Study arms

  • Experimental
    shock wave therapy

    received a program of 6 session of Shock wave Therapy on the affected wrist,5 minute per session, and a frequency of 5 Hz., 1 sessions per week for 6 weeks.

    Device: Shock wave Therapy · Device: kinesio tape

  • Experimental
    kinesio tape

    kinesio tape application on the affected wrist for 3 days and then one day off and then another 3 days each week for 6 weeks.

    Device: Shock wave Therapy · Device: kinesio tape

Interventions

  • DeviceShock wave Therapy

    a program of 6 session of Shock wave Therapy on the affected wrist,5 minute per session and a frequency of 5 Hz., 1 sessions per week for 6 weeks.

  • Devicekinesio tape

    kinesio tape application on the affected wrist for 3 days and then one day off and then another 3 days each week for 6weeks.

06

What researchers measure

Primary outcomes

  1. Computerized electromyography

    2 channel version with EMG/NCV/EP system, It was used to measure median motor distal latency (MMDL) before treatment and after 6 weeks of treatment for all patients

    Time frame: 6 weeks

Secondary outcomes

  1. Boston carpal tunnel questionnaire

    The overall score for the functional-status scale was the mean of the ratings on the 8 daily activities. In this study BCTQ was translated and filled by the therapist

    Time frame: 6 weeks

07

Study locations

1 site
  • Ghada Ebrahim Elrefaye
    Giza, 12613, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 7, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05405647
Lead sponsor
Cairo University
Responsible party
Ghada Ebrahim El Refaye (assistant professor department of Physical Therapy for Women's Health, Faculty of Physical therapy, Cairo University, Egypt, Woman's Health University Hospital, Egypt) — Principal investigator
First posted
Jun 6, 2022
Start date
Jul 1, 2021
Primary completion
Jan 29, 2022
Completion
Jan 30, 2022
Last update
Jun 7, 2022

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion